Abstract
Objective: The purpose of the study was to determine DTI properties of brain metastases in subjects with Non-Small Cell Lung Carcinoma (NSCLC) to evaluate whether there was a correlation between DTI findings and Programmed Cell Death Ligand-1 (PD-L1).
Methods: The study population (n:22) was assigned to PD-L1 negative (Group 1: PD-L1 expression<% 50) (n=11) or positive (Group 2: PD-L1 expression ≥%50) (n=11). We compared ADC and FA values measured from the enhanced solid metastases and peritumoral edema area with PD-L1 protein status.
Results: The mean ADC values were lower in group 2 compared to group 1. The peritumoral ADC values were higher in group 2 compared to group 1. Mean peritumoral edema FA values were lower in group 2 compared to group 1. The peritumoral edema nADC values were higher in group 2 compared to group 1. As PD-L1 expression frequency increased, ADC values in the peritumoral edema area increased and FA values decreased.
Conclusion: We thought that the existence of PD-L1 protein does not affect ADC and FA values of brain metastasis (BM) originating from NSCLC. DTI characteristics of the peritumoral edema area could be a guide in determining the PD-L1 protein status of brain metastases of NSCLC. The relationship between PD-L1 expression status and DTI features in BM from NSCLC could help us to have an idea regarding the response to immunotherapy.
Keywords: Programmed cell death ligand 1, diffusion tensor imaging, brain metastasis, non-small cell lung, immunotherapy, apparent diffusion coefficient.
Graphical Abstract
Call for Papers in Thematic Issues
Advancements and Applications of Photon Counting CT: Transforming Imaging Precision and Quantification
Photon Counting Computed Tomography (CT) represents a transformative advancement in medical imaging technology, offering unprecedented levels of precision and diagnostic capability. This special issue will explore the latest innovations and applications of photon counting CT, highlighting its advantages over traditional energy-integrating detectors. The scope includes an in-depth examination of its ...read more
AI-Driven Diagnostics in Radiology and Medical Imaging
Medical imaging data, such as X-rays, MRIs, ultrasounds, CT scans, and DXAs, can be analysed by AI algorithms to help healthcare professionals identify and diagnose diseases more rapidly and accurately. Among the most cutting-edge applications of artificial intelligence (AI) in healthcare are imaging-related applications like cancer detection. AI could revolutionise ...read more
Applying medical image processing techniques for early cancer detection in mammograms
Breast cancer survival and successful treatment are significantly boosted by early identification. Breast cancer screening is most commonly accomplished with mammography. The radiologist's experience and the image quality, among several other factors, might affect how well a mammogram is interpreted. Enhancing mammography analysis and increasing cancer early detection are made ...read more
Deep Learning Approaches for Image Enhancement in Medical Diagnostics
The medical and healthcare sectors are very different from one another. Consumers in these sectors need more affordable offerings. Health or medical specialists are typically the ones who analyze medical data. In particular, medical imaging evaluation heavily relies on machine learning and deep learning. They not only yield outstanding outcomes ...read more
24
